Summary of Study ST001680
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001079. The data can be accessed directly via it's Project DOI: 10.21228/M8797T This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
| Study ID | ST001680 |
| Study Title | Metabolome of NAFLD in high fat diet mouse model |
| Study Summary | We investigated the effects of a RAR beta 2 agonist, AC261066, on the hepatic metabolites changed in high fat fed NAFLD mouse model. We suggest that AC261066 has potential therapeutic relevance for the prevention/treatment of NAFLD and NASH. |
| Institute | Weill Cornell Medicine |
| Last Name | Gudas |
| First Name | Lorraine |
| Address | 1300 York Ave |
| chl2029@med.cornell.edu | |
| Phone | 646-3094389 |
| Submit Date | 2021-01-27 |
| Raw Data Available | Yes |
| Raw Data File Type(s) | d |
| Analysis Type Detail | LC-MS |
| Release Date | 2022-01-27 |
| Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
| Project ID: | PR001079 |
| Project DOI: | doi: 10.21228/M8797T |
| Project Title: | Metabolome of NAFLD in high fat diet mouse model |
| Project Summary: | We investigated the effects of a RAR beta 2 agonist, AC261066, on the hepatic metabolites changed in high fat fed NAFLD mouse model. We suggest that AC261066 has potential therapeutic relevance for the prevention/treatment of NAFLD and NASH. |
| Institute: | Weill Cornell Medical College |
| Laboratory: | Lorraine Gudas |
| Last Name: | Lorraine |
| First Name: | Gudas |
| Address: | 1300 York Ave, New York, NY, 10065, USA |
| Email: | chl2029@med.cornell.edu |
| Phone: | 646-3094389 |
